DNA Dollars

Genomics Research Market Worth to Exceed $31 Billion by 2027

Despite being a relatively new field in the space of biology research, genomics has made massive advances in science and medicine in the past few years. The global genomics market size is expected to reach USD 31.1 billion by 2027, registering a CAGR of 7.7% over the forecast period.
Source: sudok1/Getty Images

SomaGenics Nabs NIH Grant to Develop cfDNA Platform

RealSeq-DC builds on existing technology to allow researchers the ability to analyze and log short, single-stranded DNA fragments.
Prenatal testing offers technologies like sequencing

Prenatal Testing Upgraded with Sequencing, Microarrays, and Mass Spec

Family planning and coordination of care for a child born with health conditions are significant concerns for the in vitro diagnostics (IVD) community, which...

Microneedle Skin Patch Captures, Detects Biomarkers

Finding a biomarker using these microneedle patches is similar to blood testing. But instead of using a solution to find and quantify the biomarker in blood, the microneedles directly capture it from the liquid that surrounds our cells in skin.
New study shows that gender was the most significant attributable source of variation for regulatory elements among immune system genes. [iStock/iofoto]

Immune System Regulome Differs for Men and Women

After the completion of the Human Genome Project, one thing became abundantly clear to scientists: that they had only begun to scratch the surface...
Source: CIPhotos/Getty Images

Adding Diversity to the Reference Genome

Sequencing experts fill in gaps, confront genomic diversity, and ponder the complexities posed by multiple reference genomes
Mission Bio said today it has completed a $30 million Series B financing

With $30M Financing, Mission Bio Eyes Platform Development, Expansion into Gene Editing

After completing Series B financing, company aims to capitalize on growing interest in Tapestri platform by gene-editing-based biopharmas.
Advocacy groups have alleged that the FDA lacks statutory authority to regulate LDTs

Snapshot: LDT Labs Prepare for the Eventuality of FDA Oversight

The FDA defines a laboratory developed test (LDT) as a type of in vitro diagnostic device (IVD) intended for clinical use that is designed,...
Source: iStock/KatarzynaBialasiewicz

Horizon Discovery Group Inks Agreements with Three CDx Developers

Horizon Discovery Group said today it has signed development agreements with three undisclosed “global” developers of companion diagnostic tests totaling an initial $3.3 million. Horizon...
Harmonizing NGS standards is expected to provide a strong evidence base for decisions on coverage of clinical genomic testing and treatment for cancer. [iStock / zmeel]

Harmonizing Standards for NGS Registries and Databases

The Green Park Collaborative (GPC) and the Molecular Evidence Development Consortium (MED-C) are launching a joint effort to advance personalized medicine by harmonizing standards...


Scroll Up